Portal de investigación
CONTRATOS MIGUEL SERVET TIPO II
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
INSTITUTO SALUD CARLOS III
Resultados del Ensayo Clínico
Anti-inflammatory effects and improved metabolic derangements in ob/ob mice by a newly synthesized prenylated benzopyran with pan-PPAR activity
Marques, Patrice; (...); Cabedo, Nuria
Article. 10.1016/j.phrs.2022.106638. 2023
Development of 2-and 3-prenylated quinolines and tetrahydroquinolines with PPAR activity: From hit to lead and a novel pan-PPAR agonist as a potential candidate for metabolic syndrome
Villarroel-Vicente, C; (...); Cabedo, N
Article. 10.1016/j.bioorg.2025.108450. 2025
Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview.
Villarroel-Vicente, Carlos; (...); Cabedo, Nuria
Article. 10.1016/j.ejmech.2021.113535. 2021
Synthesis and biological studies of "Polycerasoidol" and "trans-d-Tocotrienolic acid" derivatives as PPARa and/or PPAR? agonists.
Vila, Laura; (...); Cortes, Diego
Article. 10.1016/j.bmc.2021.116532. 2022
Synthesis of 2-(3-aminopropyl)benzopyrans as potential antipsychotic agents targeting D2/D3 and 5-HT2A receptors
Bernabeu-Sanchis Á; (...); Cabedo N
Article. 10.1016/j.bmc.2025.118300. 2025
Synthesis of 2-aminopropyl benzopyran derivatives as potential agents against triple-negative breast cancer
García, A; (...); Cortes, D
Article. 10.1039/d3md00385j. 2023
Synthesis of 2-Prenylated Alkoxylated Benzopyrans by Horner-Wadsworth-Emmons Olefination with PPARa/? Agonist Activity.
Garcia, A; (...); Cortes, D
Article. 10.1021/acsmedchemlett.1c00400. 2021
